Theremia Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.26M

  • Investors
  • 12

Theremia General Information

Description

Developer of an AI-driven platform designed to improve drug efficacy and minimize side effects for diverse patients. The company's platform specializes in optimizing drug derivatives for specific population subgroups using advanced machine learning, enabling pharmaceutical industry to revolutionize drug development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 96 Bis Boulevard Raspail
  • 75006 Paris
  • France
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Corporate Office
  • 96 Bis Boulevard Raspail
  • 75006 Paris
  • France

Theremia Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theremia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 07-Nov-2024 $3.26M Completed Generating Revenue
4. Accelerator/Incubator 29-Aug-2024 Completed Generating Revenue
3. Accelerator/Incubator 07-Mar-2024 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Theremia’s complete valuation and funding history, request access »

Theremia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA 2024
To view Theremia’s complete cap table history, request access »

Theremia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theremia Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alemie Venture Venture Capital Minority
Better Angle Venture Capital Minority
Bpifrance Sovereign Wealth Fund Minority
Entrepreneurs First Venture Capital Minority
Eurazeo Asset Manager Minority
You’re viewing 5 of 12 investors. Get the full list »

Theremia FAQs

  • When was Theremia founded?

    Theremia was founded in 2023.

  • Where is Theremia headquartered?

    Theremia is headquartered in Paris, France.

  • What is the size of Theremia?

    Theremia has 4 total employees.

  • What industry is Theremia in?

    Theremia’s primary industry is Other Healthcare Technology Systems.

  • Is Theremia a private or public company?

    Theremia is a Private company.

  • What is the current valuation of Theremia?

    The current valuation of Theremia is .

  • What is Theremia’s current revenue?

    The current revenue for Theremia is .

  • How much funding has Theremia raised over time?

    Theremia has raised $3.26M.

  • Who are Theremia’s investors?

    Alemie Venture, Better Angle, Bpifrance, Entrepreneurs First, and Eurazeo are 5 of 12 investors who have invested in Theremia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process